HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Diverio Selected Research

Interleukin-3 Receptor alpha Subunit

10/2005Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression.
8/2004Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Diverio Research Topics

Disease

21BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2021 - 09/2006
18Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 10/2003
17Acute Promyelocytic Leukemia
10/2018 - 04/2002
9Leukemia
10/2022 - 08/2002
6Neoplasms (Cancer)
01/2020 - 01/2005
4Blast Crisis (Blast Phase)
01/2020 - 09/2006
4Residual Neoplasm
08/2009 - 09/2003
2Genetic Translocation (Chromosomal Translocation)
11/2007 - 10/2002
1Anemia
01/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2009
1Sarcoma (Soft Tissue Sarcoma)
02/2009
1Leukopenia
01/2008
1Thrombocytosis (Thrombocythemia)
01/2008
1Necrosis
10/2007
1Philadelphia Chromosome
09/2006
1Disease Progression
10/2004
1Hematologic Neoplasms (Hematological Malignancy)
04/2002

Drug/Important Bio-Agent (IBA)

15Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 09/2006
10Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2018 - 08/2002
8NucleophosminIBA
01/2020 - 01/2005
5Tyrosine Kinase InhibitorsIBA
05/2021 - 12/2009
4Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2002
3Interferon-alpha (Interferon Alfa)IBA
01/2016 - 02/2008
3Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
05/2011 - 12/2008
2Core Binding Factors (Core-Binding Factor)IBA
10/2022 - 10/2003
2Dasatinib (BMS 354825)FDA Link
05/2021 - 08/2009
2InterferonsIBA
01/2021 - 01/2016
2Arsenic Trioxide (Trisenox)FDA Link
10/2018 - 08/2009
2AnthracyclinesIBA
01/2018 - 08/2009
2MicroRNAs (MicroRNA)IBA
03/2008 - 11/2007
2Transcription Factors (Transcription Factor)IBA
11/2007 - 10/2003
2Gemtuzumab (Mylotarg)FDA Link
09/2007 - 10/2004
2Interleukin-3 Receptor alpha SubunitIBA
10/2005 - 08/2004
1nilotinibFDA Link
05/2021
1Azacitidine (5 Azacytidine)FDA Link
10/2020
1DecitabineFDA Link
10/2020
1Phosphotransferases (Kinase)IBA
08/2019
1ErythropoietinFDA Link
01/2019
1CD34 Antigens (CD34 Antigen)IBA
11/2014
1Indicators and Reagents (Reagents)IBA
01/2013
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2012
1Therapeutic UsesIBA
10/2011
1AntigensIBA
10/2011
1AntibodiesIBA
10/2011
1Sialic Acid Binding Ig-like Lectin 3IBA
10/2011
1bcr-abl Fusion ProteinsIBA
12/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2009
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2009
1NucleotidesIBA
03/2008
1Bortezomib (Velcade)FDA Link
10/2007
1LigandsIBA
10/2007
1Endothelial Growth FactorsIBA
08/2007
1podocalyxinIBA
11/2006
1Integrin alpha4beta1 (VLA-4)IBA
11/2006
1ParaffinIBA
09/2006
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2006
1Interleukin-3 (Interleukin 3)IBA
10/2005
1Diphtheria ToxinIBA
10/2005
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
10/2005
1MethyltransferasesIBA
03/2005
1Retinoic Acid Receptor alphaIBA
03/2005
1DNA (Deoxyribonucleic Acid)IBA
03/2005
1ChromatinIBA
03/2005
1Histone Deacetylases (Histone Deacetylase)IBA
03/2005
1PAX5 Transcription FactorIBA
10/2004
1Monoclonal AntibodiesIBA
10/2004
1CCAAT-Enhancer-Binding Protein-alphaIBA
10/2003
1Green Fluorescent ProteinsIBA
10/2002
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
10/2002
1Genetic Markers (Genetic Marker)IBA
04/2002

Therapy/Procedure

10Therapeutics
05/2021 - 09/2003
7Drug Therapy (Chemotherapy)
10/2022 - 01/2004
1Stem Cell Transplantation
10/2022
1Salvage Therapy
01/2012
1Transplantation
01/2012